This inventor holds 1 USPTO granted patent. Top assignee: Biophore India Pharmaceuticals Pvt. Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: **Innovative Contributions of Surya Bala Subrahmanyam Pendyala in Pharmaceutical Chemistry**
Introduction
Surya Bala Subrahmanyam Pendyala, an esteemed inventor based in Hyderabad, Telangana, India, has made a noteworthy impact in the field of pharmaceutical chemistry. His dedication to innovation and advancement in drug synthesis has culminated in a patent that exemplifies his expertise and contribution to the industry.
Latest Patents
Pendyala holds a patent for his groundbreaking work titled, "Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide." This invention details novel methods for the preparation of Carfilzomib and its intermediates, demonstrating high stereo selection. The synthetic procedures outlined in the patent result in substantially pure Carfilzomib, showcasing Pendyala's contribution to enhancing drug development processes.
Career Highlights
Surya Bala Subrahmanyam Pendyala is currently associated with Biophore India Pharmaceuticals Pvt. Ltd., where he continues to drive innovation in the pharmaceutical sector. His expertise in synthesis and chemical processes has positioned him as a key player in developing advanced pharmaceutical solutions.
Collaborations
Pendyala has collaborated with fellow professionals, including Manik Reddy Pullagurla and Jagadeesh Babu Rangisetty. These partnerships highlight the importance of teamwork in scientific research and development, facilitating the sharing of knowledge and expertise to achieve common goals in the realm of drug synthesis.
Conclusion
The contributions of Surya Bala Subrahmanyam Pendyala exemplify the spirit of innovation that drives the pharmaceutical industry forward. His patented methods for the preparation of Carfilzomib not only illustrate his technical proficiency but also signify the continuing evolution of pharmaceutical chemistry. As he continues his work at Biophore India Pharmaceuticals Pvt. Ltd., Pendyala's future endeavors are sure to further enhance the landscape of drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile